Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
about
Refractory and Resistant Hypertension: Antihypertensive Treatment Failure versus Treatment ResistanceThe Effect of Renal Denervation on Plasma Adipokine Profile in Patients with Treatment Resistant Hypertension.Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study.Hypertension: How should data from SYMPLICITY HTN-3 be interpreted?Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.Lifestyle modification for resistant hypertension: The TRIUMPH randomized clinical trialPrevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension.Cardiovascular and renal complications in patients with resistant hypertension.Invasive treatment of resistant hypertension: present and future.The ROX coupler: creation of a fixed iliac arteriovenous anastomosis for the treatment of uncontrolled systemic arterial hypertension, exploiting the physical properties of the arterial vasculature.Resistant hypertension: what the cardiologist needs to know.Resistant Hypertension: Mechanisms and Treatment.Recognition and Management of Resistant Hypertension.Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT.Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension.Mortality Risk Associated With Resistant Hypertension Among Women: Analysis from Three Prospective Cohorts Encompassing the Spectrum of Women's Heart Disease.Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension.Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.Health-related quality of life in persons with apparent treatment-resistant hypertension on at least four antihypertensives.Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.Resistant hypertension: a therapeutic challenge.Resistant Hypertension and Susceptible Outcomes: Exploring the Benefits of Aggressive Blood Pressure Control.
P2860
Q28078151-C6D90B8F-A7A5-4F8E-A832-FD605C7D8DC7Q33736684-885CEEEA-5AD0-4AB6-9885-A54B52A3E97DQ34051223-CFF0454D-1427-4EEB-BDC1-13E3AF04681FQ35170709-94BD9F06-7603-4B5D-ABC7-00F2C91F661BQ36016796-C0455612-0239-4A69-A739-33E92BBB9B09Q36258974-9A26A42B-705A-4D33-9A63-222A145E5B5BQ36463881-335FC971-9B9F-4819-9887-3868351E8F0FQ36792041-1776D054-2D8D-42DD-89B9-9440716F1AFCQ37556484-FCB78799-7E73-4A2E-A9D6-31D4F29A1F9AQ38235630-4C114284-E9E4-4782-ACE3-FD4C564E5991Q38245560-85E7DE55-19F1-4793-B047-935BA57C6C2BQ38262779-40CA1BD3-DD84-42ED-BB13-A0DB3C291600Q38564177-D4A20333-821A-4BA6-BF87-6DE0DB0E1634Q38734859-C488F5D2-B52D-439F-A3E1-74F7225F7115Q38789707-AF0E24EA-1B6C-469B-AAB7-73E161272C8CQ38891249-ACE05A77-D249-403A-906E-A9853BB8FCDFQ39262972-B8489E21-3D2B-4D01-A8A7-8529423163F6Q39736861-A25A3C0D-AEEF-4798-9952-3512D276E9B8Q40013669-F28B1212-24A0-47A8-B15B-FE51E53BD3B5Q40052463-8232B8DB-42F2-417E-89E7-954618F0D2F1Q40826247-9EDCECD1-2128-4223-B2AC-B4A5536A6FB7Q42373752-2950647F-BCB3-4CF1-96D3-8748D28CDE83Q48279650-EC695CDE-EFDA-4460-856D-E3225DD29A2DQ53814916-1F9F6021-36A8-4FD6-9DB4-58B12B57949E
P2860
Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Prevalence, predictors, and ou ...... atients with coronary disease.
@en
Prevalence, predictors, and ou ...... atients with coronary disease.
@nl
type
label
Prevalence, predictors, and ou ...... atients with coronary disease.
@en
Prevalence, predictors, and ou ...... atients with coronary disease.
@nl
prefLabel
Prevalence, predictors, and ou ...... atients with coronary disease.
@en
Prevalence, predictors, and ou ...... atients with coronary disease.
@nl
P2093
P1476
Prevalence, predictors, and ou ...... atients with coronary disease.
@en
P2093
David A Demicco
Franz H Messerli
John B Kostis
Prakash Deedwania
Rachel Laskey
Rana Fayyad
Treating to New Targets Steering Committee and Investigators
P304
P356
10.1016/J.AMJMED.2013.07.038
P407
P577
2013-11-07T00:00:00Z